← Leaderboards
Edward Castillo
Thomas Jefferson University
$1,750,186
Attributed
$4,948,657
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,948,657 · 5
By mechanism
R01$3,075,324 · 2
UH3$1,058,781 · 1
UG3$663,601 · 1
R03$150,951 · 1
Top collaborators
- Richard Castillo18 shared
- Yevgeniy Vinogradskiy18 shared
- Girish Balachandran Nair2 shared
- Lili Zhao2 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Yevgeniy Vinogradskiy$2,110,476
- Richard Castillo$1,839,589
- Bruno Calabretta$9,620,602
Others in their field
Other Emerging Leaders on “Malignant Neoplasm Of Lung”
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
- Greg Yothers · University Of Chicago$35,003,821
- Lynn Briscoe · Leidos Biomedical Research, Inc.$26,085,158
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,658,268
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- John Freymann · Leidos Biomedical Research, Inc.$14,011,208
Research focus
Malignant Neoplasm Of LungVentilationImageLungSide EffectChestValidationRadiation PneumonitisRadiation TherapyPulmonary FunctionProspectiveMapsRadiationClinically SignificantStandard Of CareInnovationImaging ModalityImproved OutcomeDoseComputer SoftwareData SetClinical TrialsClinical CareCancer Patient
Grant awards (21)
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$420,407
UH3 · FY2025 · CA
CT-Derived Functional Imaging for Predicting Disease Progression in COPD$349,648
R01 · FY2025 · HL · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$320,465
R01 · FY2025 · CA
Computational Breathing Model for Robust Lung Function Assessment$150,951
R03 · FY2025 · EB · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$30,947
R01 · FY2025 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$15,043
R01 · FY2025 · CA
CT-Derived Functional Imaging for Predicting Disease Progression in COPD$363,700
R01 · FY2024 · HL · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$348,431
R01 · FY2024 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$223,430
UH3 · FY2024 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$130,633
R01 · FY2024 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$28,114
R01 · FY2024 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$414,944
UH3 · FY2023 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$394,941
R01 · FY2023 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$102,351
R01 · FY2023 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$14,549
R01 · FY2023 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$316,568
UG3 · FY2022 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$118,825
R01 · FY2022 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$383,072
R01 · FY2021 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$347,033
UG3 · FY2021 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$75,749
R01 · FY2021 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$398,856
R01 · FY2020 · CA